Drug-Sensitized Yeast System Enhances mTOR Inhibitor Discove
2026-06-25
The referenced study introduces a yeast-based screening platform with heightened sensitivity for identifying mTOR inhibitors by exploiting specific genetic backgrounds and drug efflux deletions. This innovation promises to accelerate the discovery of novel geroprotective and anti-cancer agents, while also providing valuable negative data for compounds such as Nebivolol hydrochloride.
Trichostatin A (TSA): Data-Driven Solutions for Cell Assays
2026-06-25
This scenario-driven guide addresses key experimental challenges in cell viability, proliferation, and cytotoxicity assays, showing how Trichostatin A (TSA, SKU A8183) from APExBIO delivers reproducible, literature-backed outcomes. Focused on practical optimization and robust epigenetic insights, it provides researchers with actionable, evidence-based strategies for integrating TSA into cancer and epigenetic research workflows.
Gepotidacin (GSK2140944): Protocols for Antibacterial Resear
2026-06-24
Gepotidacin (GSK2140944) stands out as a first-in-class DNA gyrase inhibitor, empowering researchers to tackle antibiotic resistance with precision. This article delivers practical workflows, protocol parameters, and troubleshooting insights to unlock Gepotidacin’s full potential in advanced antibacterial research.
Eltanexor (KPT-8602): Optimizing Nuclear Export Inhibition i
2026-06-23
Eltanexor (KPT-8602) empowers translational oncology with its potent, second-generation inhibition of XPO1-mediated nuclear export and exceptional tolerability across hematologic and solid tumor models. Explore stepwise protocols, experiment-driven troubleshooting, and the latest cross-cancer insights for deploying this oral bioavailable XPO1 inhibitor in advanced research applications.
Recombinant Human EGF: Mechanisms, Synthetic Lethality, and
2026-06-23
Explore the multifaceted roles of recombinant human Epidermal Growth Factor (EGF) in cell signaling, synthetic lethality, and translational research. This article uniquely integrates mechanistic depth, practical protocol advice, and novel insights from recent chemogenetic screens, offering a comprehensive resource for advanced cell biology and oncology studies.
Continuous Rotigotine Delivery in PD and RLS: Study Insights
2026-06-22
This review details the innovation and clinical validation of continuous rotigotine transdermal delivery for Parkinson’s disease and restless legs syndrome. The study highlights how sustained dopaminergic stimulation via a non-ergoline dopamine D2/D3 receptor agonist improves both motor and non-motor symptoms, addressing limitations of short-acting oral therapies.
WY-14643 (Pirinixic Acid): Precision Tool for Metabolic Rese
2026-06-22
WY-14643 (Pirinixic Acid) offers unmatched selectivity and potency for dissecting PPARα-driven metabolic and inflammatory pathways in preclinical models. This article explores optimized workflows, troubleshooting guidance, and key innovations in liver regeneration research leveraging APExBIO’s trusted compound.
Melittin: Bioactive Peptide Workflows in Cancer Biology Rese
2026-06-21
Melittin empowers researchers to modulate cell signaling pathways with precision, uniquely enabling advanced signal transduction and apoptosis research. This guide translates the latest glioblastoma findings into actionable workflows and troubleshooting strategies for maximizing the peptide's utility in cancer biology.
Cy5.5 NHS Ester (Non-Sulfonated): Optimizing In Vivo Imaging
2026-06-20
Cy5.5 NHS ester (non-sulfonated) stands out as a gold-standard near-infrared dye for protein and nanoparticle labeling, enabling deep-tissue, high-precision optical imaging. This guide details best practices, protocol optimizations, and troubleshooting for applying Cy5.5 NHS ester to advanced workflows such as blood-brain barrier-crossing nanoparticle tracking and tumor visualization.
Regorafenib Suppresses Melanoma via RRM2 and ERK/E2F3 Downre
2026-06-19
A recent study demonstrates that Regorafenib (BAY 73-4506) inhibits melanoma progression by downregulating RRM2 and disrupting ERK/E2F3 signaling, leading to reduced proliferation and increased apoptosis in melanoma cells. These findings refine the mechanistic understanding of Regorafenib’s antitumor action and offer new directions for targeted melanoma research.
Calpain Inhibitor I, ALLN: Technical Guide for Apoptosis & I
2026-06-19
Calpain Inhibitor I, ALLN enables researchers to selectively inhibit calpain and cathepsin proteases in apoptosis assays, inflammation research, and ischemia-reperfusion injury models. It should not be used in workflows requiring water solubility or maximal specificity for a single protease. This reagent is intended strictly for laboratory research and not for diagnostic or medical applications.
Ceftazidime in Translational Research: Mechanistic and Strat
2026-06-18
Explore how Ceftazidime, a third-generation cephalosporin, shapes translational research into Gram-negative resistance, with a focus on emerging multidrug-resistant Enterobacter cloacae. This article combines biological rationale, experimental strategies, resistance dynamics, and actionable guidance for researchers, contextualized by recent molecular epidemiology from Guangdong's teaching hospitals and competitive perspectives on cephalosporin use.
Clodronate Liposomes: Unraveling Macrophage Roles In Vivo
2026-06-18
Explore the mechanistic underpinnings and translational value of Clodronate Liposomes for in vivo macrophage depletion, spotlighting recent advances in immune modulation and experimental strategy. This article offers actionable guidance for translational researchers, blending rigorous scientific insight with strategic workflow recommendations and real-world benchmarking against emerging literature.
Organic Cation Transporter Response to Olsalazine in Mosquit
2026-06-17
Kennel and Rouhier (2025) investigated how Aedes aegypti mosquitoes process xenobiotic dyes, including Olsalazine Sodium, focusing on excretion patterns and the expression of novel organic cation transporter genes. Their findings indicate that the molecular structure of foreign compounds, rather than major gene expression changes, governs excretion dynamics and mosquito mortality, offering new directions for vector control research.
Pseudo-UTP for Enhanced mRNA Synthesis: Protocols & Use-Case
2026-06-17
Pseudo-modified uridine triphosphate (Pseudo-UTP) transforms mRNA synthesis by boosting RNA stability, translation efficiency, and reducing immunogenicity. This guide delivers actionable workflows, troubleshooting insights, and research-backed protocol optimizations for advanced mRNA vaccine and gene therapy applications.
459 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page